BE708434A - - Google Patents
Info
- Publication number
- BE708434A BE708434A BE708434DA BE708434A BE 708434 A BE708434 A BE 708434A BE 708434D A BE708434D A BE 708434DA BE 708434 A BE708434 A BE 708434A
- Authority
- BE
- Belgium
- Prior art keywords
- sep
- tablets
- wax
- fat
- acid acceptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1836366 | 1966-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE708434A true BE708434A (de) | 1968-05-02 |
Family
ID=4432451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE708434D BE708434A (de) | 1966-12-22 | 1967-12-22 |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE708434A (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2471784A1 (fr) * | 1979-12-21 | 1981-06-26 | Roussel Uclaf | Medicaments antiarythmiques a action prolongee dont le principe actif est le a/2-/bis (1-methylethyl) amino/ethyl/-a-phenyl-2-pyridine acetamide ou ses sels, ainsi que le procede de preparation de ces nouveaux medicaments et compositions les renfermant |
WO1982004392A1 (en) * | 1981-06-18 | 1982-12-23 | Uclaf Roussel | Method of preparing pharmaceutical compositions containing alpha-/2-/bis(1-methylethyl)amino/ethyl/alpha-phenyl 2-pyridine acetamide or one of its salts |
FR2537434A1 (fr) * | 1982-12-09 | 1984-06-15 | Sandoz Sa | Composition pharmaceutique d'endralazine sous forme retard |
-
1967
- 1967-12-22 BE BE708434D patent/BE708434A/fr unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2471784A1 (fr) * | 1979-12-21 | 1981-06-26 | Roussel Uclaf | Medicaments antiarythmiques a action prolongee dont le principe actif est le a/2-/bis (1-methylethyl) amino/ethyl/-a-phenyl-2-pyridine acetamide ou ses sels, ainsi que le procede de preparation de ces nouveaux medicaments et compositions les renfermant |
WO1982004392A1 (en) * | 1981-06-18 | 1982-12-23 | Uclaf Roussel | Method of preparing pharmaceutical compositions containing alpha-/2-/bis(1-methylethyl)amino/ethyl/alpha-phenyl 2-pyridine acetamide or one of its salts |
FR2537434A1 (fr) * | 1982-12-09 | 1984-06-15 | Sandoz Sa | Composition pharmaceutique d'endralazine sous forme retard |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0320051B1 (de) | Carbidopa-Levodopa-Zusammensetzung mit gesteuerter Freigabe | |
US4900755A (en) | Controlled release combination of carbidopa/levodopa | |
US4983400A (en) | Controlled release combination of carbidopa/levodopa | |
BE1014328A7 (fr) | Composition pharmaceutique orale a liberation controlee. | |
EP0253490B1 (de) | Kombination von Carbidopa/Levodopa mit verzögerter Wirkstoffabgabe | |
CA2101164C (fr) | Medicaments administrables par voie orale, pour le traitement de la carence en dopamine du systeme nerveux central | |
FR2547498A1 (fr) | Comprimes de naproxen et de naproxen sodique a liberation controlee | |
EA021763B1 (ru) | Твердая фармацевтическая композиция, содержащая амлодипин и лозартан, с улучшенной стабильностью | |
FR2512676A1 (fr) | Composition a liberation commandee hydrodynamiquement equilibree | |
HU217818B (hu) | Eljárás magas hatóanyag-tartalmú granulátumok, pelletek és tabletták előállítására | |
OA10336A (fr) | Association thérapeutique vitamino-calcique sous forme galénique unitaire de comprimés son procédé d'obtention et son utilisation | |
FR2540727A1 (fr) | Nouvelle preparation retard contenant de la n''-cyano-n-4-pyridyl-n'-1,2,2-trimethylpropylguanidine, utile notamment dans le traitement de l'hypertension | |
BE708434A (de) | ||
BE1015413A6 (fr) | Systeme de delivrance orale controlee d'un medicament. | |
FR2604902A1 (fr) | Compositions pharmaceutiques a liberation prolongee | |
BE1004243A3 (fr) | Compositions pharmaceutiques du type a liberation prolongee destinees a l'administration par voie orale et leur procede de preparation. | |
FR2820423A1 (fr) | Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations | |
EP0542979A1 (de) | Magnesiumhaltiges Arzneimittel mit verlängerter Wirkstoffabgabe | |
EP0412877A1 (de) | Orale Arzneiform zur Verbesserung der Bioverfügbarkeit | |
FR2526004A1 (fr) | Nouvelles argiles ameliorees et leur procede de preparation | |
CA2274934A1 (fr) | Comprimes pharmaceutiques a liberation prolongee a base de tramadol et leur preparation | |
WO2010029037A1 (fr) | Composition de nimesulide orodispersible | |
WO2000025749A9 (fr) | Utilisation de gommes xanthanes pour la preparation de compositions pharmaceutiques | |
BE891754A (fr) | Suppositoires a base d'indomethacine et leur preparation | |
BE631171A (de) |